Dai-ichi Karkaria Limited's Board of Directors approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The results, audited by B S R & Co. LLP with an unmodified opinion, reflect a challenging year for the specialty chemicals company, with both revenue and profitability declining on a year-on-year basis. The Board also recommended a final dividend of Rs. 1.50 per share for FY26, subject to shareholder approval at the 66th Annual General Meeting.

Standalone Financial Performance

Dai-ichi Karkaria's standalone revenue from operations declined to Rs. 16,130 lakhs in FY26 from Rs. 18,138 lakhs in FY25. Total income, including other income of Rs. 735 lakhs (FY25: Rs. 446 lakhs), stood at Rs. 16,865 lakhs compared to Rs. 18,584 lakhs in the prior year. Total expenses for FY26 were Rs. 16,892 lakhs against Rs. 17,890 lakhs in FY25, resulting in a loss before exceptional items of Rs. 27 lakhs versus a profit of Rs. 694 lakhs in FY25.

The following table summarises the key standalone financial metrics:

Among key expense line items, cost of materials consumed declined to Rs. 10,524 lakhs from Rs. 11,524 lakhs, while employee benefits expenses rose to Rs. 2,566 lakhs from Rs. 2,277 lakhs. Finance costs reduced significantly to Rs. 95 lakhs from Rs. 183 lakhs. An exceptional item of Rs. 20 lakhs was recognised during FY26 on account of the one-time impact of the new Labour Code notified by the Government of India on November 21, 2025, consolidating 29 existing labour laws.

Standalone Balance Sheet Highlights

The standalone balance sheet as at March 31, 2026 reflects total assets of Rs. 20,155 lakhs compared to Rs. 20,964 lakhs as at March 31, 2025. Total non-current assets stood at Rs. 13,650 lakhs (FY25: Rs. 13,952 lakhs), while total current assets were Rs. 6,505 lakhs (FY25: Rs. 7,012 lakhs). Equity attributable to equity holders stood at Rs. 16,214 lakhs, with equity share capital of Rs. 745 lakhs and other equity of Rs. 15,469 lakhs. Total current liabilities decreased to Rs. 3,625 lakhs from Rs. 4,154 lakhs.

Quarterly Performance — Q4 FY26 vs Q4 FY25

For the quarter ended March 31, 2026, standalone revenue from operations was Rs. 4,125 lakhs, significantly lower than Rs. 7,006 lakhs in the corresponding quarter of FY25. The company reported a standalone net loss of Rs. 89 lakhs for Q4 FY26, compared to a net profit of Rs. 491 lakhs in Q4 FY25. Basic and diluted EPS for Q4 FY26 stood at Rs. (1.19) versus Rs. 6.58 in Q4 FY25.

Consolidated Financial Performance

On a consolidated basis, which includes subsidiary Dai-Ichi Gosei Chemicals (India) Limited and joint venture ChampionX Dai-Ichi India Private Limited, revenue from operations for FY26 was Rs. 16,130 lakhs (FY25: Rs. 18,138 lakhs). Total consolidated income stood at Rs. 16,595 lakhs versus Rs. 18,584 lakhs in FY25. After accounting for a share of profit in joint ventures of Rs. 250 lakhs (FY25: Rs. 284 lakhs), the consolidated net loss after non-controlling interest was Rs. 74 lakhs for FY26 compared to a net profit of Rs. 902 lakhs in FY25. Consolidated total comprehensive loss was Rs. 92 lakhs versus comprehensive income of Rs. 890 lakhs in FY25. Consolidated basic and diluted EPS stood at Rs. (0.99) for FY26 against Rs. 12.11 in FY25. Consolidated total assets were Rs. 22,404 lakhs as at March 31, 2026 compared to Rs. 23,234 lakhs as at March 31, 2025.

Dividend and Segment Information

The Board of Directors recommended a final dividend of 15%, i.e., Rs. 1.50 per equity share of face value Rs. 10/- each for FY26, compared to Rs. 3.50 per share in the previous year. The dividend is subject to shareholder approval at the ensuing 66th Annual General Meeting, and will be paid within 30 days from the date of declaration. The company operates in a single reportable segment — Specialty Chemicals — as concluded by management pursuant to Ind AS 108. The company has confirmed it is not a Large Corporate entity as per the applicable SEBI Master Circular.

Dai-ichi Karkaria Limited has informed the stock exchanges about its upcoming board meeting scheduled for Friday, May 8, 2026. The meeting has been convened to address key financial matters for the quarter and financial year ended March 31, 2026.

Key Agenda Items

The board meeting will focus on two primary matters of significant importance to shareholders and stakeholders:

Trading Window Restrictions

In compliance with the company's Code of Conduct to Regulate, Monitor and Report Trading by Designated Persons, Dai-ichi Karkaria Limited has implemented trading restrictions. The trading window for designated persons and their immediate relatives has been closed since April 1, 2026.

The trading window will remain closed until 48 hours after the audited financial results for the quarter and financial year ended March 31, 2026, are made public on May 8, 2026. This measure ensures compliance with insider trading regulations and maintains market integrity.

Regulatory Compliance

The board meeting intimation has been issued pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Company Secretary and Compliance Officer Ankit Shah signed the formal communication to BSE Limited on April 30, 2026.

The announcement demonstrates the company's commitment to maintaining transparency and adhering to regulatory requirements in its corporate governance practices.